Xi'an International Medical Investment Company Limited

Total Valuation

Xi'an International Medical Investment Company Limited carries a market capitalization of 8.93B, placing it among publicly traded companies globally. Its enterprise value stands at 15.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Xi'an International Medical Investment Company Limited currently has 2.24B shares outstanding.

Valuation Ratios

The price-to-sales ratio is 2.66, and the price-to-book ratio stands at 5.62.

Enterprise Valuation

Financial Position

Xi'an International Medical Investment Company Limited maintains a current ratio of 0.28, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 138.67, indicating elevated leverage, while an interest coverage ratio of -1.64 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Xi'an International Medical Investment Company Limited's stock has declined approximately -22.82398% over the past 52 weeks. The 50-day moving average sits at 4.28, while the 200-day moving average is 4.71.

Income Statement

Over the trailing twelve months, Xi'an International Medical Investment Company Limited generated 4.43B in revenue and converted that into -245.48M in net income, yielding earnings per share of -0.16. EBITDA reached -257.14M, while operating income came in at -257.14M.

Balance Sheet

Xi'an International Medical Investment Company Limited holds 413.15M in cash and equivalents against 4.45B in total debt, resulting in a net debt position of 3.06B. Total book value stands at 2.09B, with working capital of -3.02B providing operational flexibility.

Cash Flow

After subtracting -388.98M in capital expenditures, free cash flow totaled -388.98M - equivalent to -0.17 per share.

Margins

Xi'an International Medical Investment Company Limited operates with a gross margin of 8.67, reflecting its pricing power and cost economics. The operating margin of -5.81 and net profit margin of -5.54 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -34.46 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Xi'an International Medical Investment Company Limited's most recent stock split took place on May 19, 2016 with a 2:5 split ratio.

Scores

Xi'an International Medical Investment Company Limited posts an Altman Z-Score of 1.01, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.